我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
2
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2016
尚未招募
100.0%
暂无批准数据
- Gummies have emerged as the second-best selling delivery format in the vitamins and supplements market, showing potential for pharmaceutical applications to improve patient compliance. - Manufacturing gummy-based pharmaceuticals faces significant technical challenges, including API stabilization, taste masking, and the need for precise temperature control during production. - While no FDA-approved gummy-based drugs exist yet, the regulatory environment shows potential openness, with Seattle Gummy Company achieving the first IND approval for an allergy medication in 2020.
